OBJECTIVE: Cancer caregiving burden is known to vary across the survivorship trajectory and has been linked with caregivers' subsequent health impairment. Little is known, however, regarding how risk factors during long-term survivorship relate to vulnerability to caregivers' health during that period. This study examined effects of caregiving status and depressive symptoms on development of physical morbidity by 5 years postdiagnosis. METHOD: Family caregivers (N = 491; Mage = 55.78) completed surveys at 2 (Time 1 [T1]) and 5 years (T2) after their care recipients' cancer diagnosis. Demographic and caregiving context variables known to affect caregivers' health were assessed at T1. Self-reported depressive symptoms and a list of physical morbid conditions were assessed at T1 and T2. Caregiving status (former, current, or bereaved) was assessed at T2. RESULTS: Hierarchical negative binomial regression revealed that current caregivers at T2 (p = .02), but not those bereaved by T2 (p = .32), developed more physical morbid conditions between T1 and T2 compared with former caregivers, controlling for other variables. Independently, caregivers reporting either newly emerging or chronically elevated depressive symptoms at T2 (ps < .03), but not those whose symptoms remitted at T2 (p = .61), showed greater development of physical morbidity than did those reporting minimal depressive symptoms at both T1 and T2. CONCLUSIONS: Results highlight the roles of long-term caregiving demands and depressive symptoms in cancer caregivers' premature physical health decline. Clinical attention through the long-term survivorship trajectory should be emphasized for caregivers of patients with recurrent or prolonged illness and to address caregivers' elevated depressive symptoms. (PsycINFO Database Record (c) 2017 APA, all rights reserved).
OBJECTIVE:Cancer caregiving burden is known to vary across the survivorship trajectory and has been linked with caregivers' subsequent health impairment. Little is known, however, regarding how risk factors during long-term survivorship relate to vulnerability to caregivers' health during that period. This study examined effects of caregiving status and depressive symptoms on development of physical morbidity by 5 years postdiagnosis. METHOD: Family caregivers (N = 491; Mage = 55.78) completed surveys at 2 (Time 1 [T1]) and 5 years (T2) after their care recipients' cancer diagnosis. Demographic and caregiving context variables known to affect caregivers' health were assessed at T1. Self-reported depressive symptoms and a list of physical morbid conditions were assessed at T1 and T2. Caregiving status (former, current, or bereaved) was assessed at T2. RESULTS: Hierarchical negative binomial regression revealed that current caregivers at T2 (p = .02), but not those bereaved by T2 (p = .32), developed more physical morbid conditions between T1 and T2 compared with former caregivers, controlling for other variables. Independently, caregivers reporting either newly emerging or chronically elevated depressive symptoms at T2 (ps < .03), but not those whose symptoms remitted at T2 (p = .61), showed greater development of physical morbidity than did those reporting minimal depressive symptoms at both T1 and T2. CONCLUSIONS: Results highlight the roles of long-term caregiving demands and depressive symptoms in cancer caregivers' premature physical health decline. Clinical attention through the long-term survivorship trajectory should be emphasized for caregivers of patients with recurrent or prolonged illness and to address caregivers' elevated depressive symptoms. (PsycINFO Database Record (c) 2017 APA, all rights reserved).
Authors: B W Penninx; J M Guralnik; M Pahor; L Ferrucci; J R Cerhan; R B Wallace; R J Havlik Journal: J Natl Cancer Inst Date: 1998-12-16 Impact factor: 13.506
Authors: Elizabeth R Kessler; Angela Moss; S Gail Eckhardt; Mark L Laudenslager; Kristin Kilbourn; Iris B Mauss; Daniel W Bowles; Sharon Hecker; Diane L Fairclough; Jean S Kutner Journal: Support Care Cancer Date: 2014-08-15 Impact factor: 3.603
Authors: Tenbroeck Smith; Kevin D Stein; C Christina Mehta; Chiewkwei Kaw; James L Kepner; Trent Buskirk; Jeremy Stafford; Frank Baker Journal: Cancer Date: 2007-01-01 Impact factor: 6.860
Authors: C Nijboer; R Tempelaar; R Sanderman; M Triemstra; R J Spruijt; G A van den Bos Journal: Psychooncology Date: 1998 Jan-Feb Impact factor: 3.894
Authors: Eva Grunfeld; Doug Coyle; Timothy Whelan; Jennifer Clinch; Leonard Reyno; Craig C Earle; Andrew Willan; Raymond Viola; Marjorie Coristine; Teresa Janz; Robert Glossop Journal: CMAJ Date: 2004-06-08 Impact factor: 8.262
Authors: Brenda K Edwards; Anne-Michelle Noone; Angela B Mariotto; Edgar P Simard; Francis P Boscoe; S Jane Henley; Ahmedin Jemal; Hyunsoon Cho; Robert N Anderson; Betsy A Kohler; Christie R Eheman; Elizabeth M Ward Journal: Cancer Date: 2013-12-16 Impact factor: 6.860
Authors: Ellenor Mittendorfer-Rutz; Syed Rahman; Antti Tanskanen; Maila Majak; Juha Mehtälä; Fabian Hoti; Erik Jedenius; Dana Enkusson; Amy Leval; Jan Sermon; Heidi Taipale; Jari Tiihonen Journal: Schizophr Bull Date: 2019-06-18 Impact factor: 9.306
Authors: Michelle Rozwadowski; Manasa Dittakavi; Amanda Mazzoli; Afton L Hassett; Thomas Braun; Debra L Barton; Noelle Carlozzi; Srijan Sen; Muneesh Tewari; David A Hanauer; Sung Won Choi Journal: JMIR Res Protoc Date: 2020-09-18
Authors: Pinky Shani; Kristin Raeesi; Eli Walter; Kai Lewis; Wanyi Wang; Lorenzo Cohen; Gloria Y Yeh; Cecile A Lengacher; Peter M Wayne Journal: Pilot Feasibility Stud Date: 2021-03-19
Authors: Noelle E Carlozzi; Sung Won Choi; Zhenke Wu; Jennifer A Miner; Angela K Lyden; Christopher Graves; Jitao Wang; Srijan Sen Journal: JMIR Res Protoc Date: 2021-12-09
Authors: Areej El-Jawahri; Joseph A Greer; Elyse R Park; Vicki A Jackson; Mihir Kamdar; Simone P Rinaldi; Emily R Gallagher; Annemarie D Jagielo; Carlisle E W Topping; Madeleine Elyze; Bailey Jones; Jennifer S Temel Journal: J Pain Symptom Manage Date: 2020-08-31 Impact factor: 3.612